Evidence map›Paper›PMID 39370451›Full record

ArticleCommunications biology2024

Cryo-EM analysis of Pseudomonas phage Pa193 structural components.

Stephano M Iglesias, Chun-Feng David Hou, Johnny Reid, Evan Schauer, Renae Geier, Angela Soriaga, Lucy Sim, Lucy Gao, Julian Whitelegge, Pierre Kyme and 3 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structural atlas ofbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Review
  9. Viruses · 2025
    Article
  10. Article
  11. Article
  12. Journal of virology · 2025
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Stephano M IglesiasDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, USA.ORCID 0000-0003-0235-5510
Chun-Feng David HouDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, USA.
Johnny ReidArmata Pharmaceuticals Inc., Los Angeles, USA.
Evan SchauerArmata Pharmaceuticals Inc., Los Angeles, USA.
Renae GeierArmata Pharmaceuticals Inc., Los Angeles, USA.
Angela SoriagaArmata Pharmaceuticals Inc., Los Angeles, USA.
Lucy SimArmata Pharmaceuticals Inc., Los Angeles, USA.
Lucy GaoPasarow Mass Spectrometry Laboratory, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, USA.
Julian WhiteleggePasarow Mass Spectrometry Laboratory, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, USA.
Pierre KymeArmata Pharmaceuticals Inc., Los Angeles, USA.
Deborah BirxArmata Pharmaceuticals Inc., Los Angeles, USA.
Sebastien LemireArmata Pharmaceuticals Inc., Los Angeles, USA.
Gino CingolaniDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, USA. gcingola@uab.edu.ORCID 0000-0002-9206-9640

Funding

Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
Mechanism of Viral Genome Delivery into CellsR35GM140733 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CINGOLANI, GINO · 2021 to 2025
$2.8M
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocationR01GM100888 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI CINGOLANI, GINO · 2012 to 2020
$2.5M
A New Cryo-Transmission Electron Microscope at Thomas Jefferson UniversityS10OD030457 · OD · THOMAS JEFFERSON UNIVERSITY · PI CINGOLANI, GINO · 2022 to 2022
$2.0M
Towards the Development of Engineered Phage Therapeutics against MDR PathogensR21AI121531 · NIAID · SYNTHETIC GENOMICS VACCINES, INC. · PI BARBU, ELENA M · 2016 to 2017
$388k
NIAID NIH HHS R21 AI121531NIGMS NIH HHS R01 GM100888NIGMS NIH HHS R35 GM140733NIGMS NIH HHS U24 GM129547NIH HHS S10 OD030457U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM100888U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM140733U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) U24GM129547
6 · The paper itself

Abstract

The World Health Organization has designated Pseudomonas aeruginosa as a critical pathogen for the development of new antimicrobials. Bacterial viruses, or bacteriophages, have been used in various clinical settings, commonly called phage therapy, to address this growing public health crisis. Here, we describe a high-resolution structural atlas of a therapeutic, contractile-tailed Pseudomonas phage, Pa193. We used bioinformatics, proteomics, and cryogenic electron microscopy single particle analysis to identify, annotate, and build atomic models for 21 distinct structural polypeptide chains forming the icosahedral capsid, neck, contractile tail, and baseplate. We identified a putative scaffolding protein stabilizing the interior of the capsid 5-fold vertex. We also visualized a large portion of Pa193 ~ 500 Å long tail fibers and resolved the interface between the baseplate and tail fibers. The work presented here provides a framework to support a better understanding of phages as biomedicines for phage therapy and inform engineering opportunities.

Indexed as

Cryoelectron MicroscopyPseudomonas PhagesCapsid ProteinsModels, MolecularPseudomonas aeruginosaCapsid Proteins

Identifiers

PMID39370451
PMCPMC11456595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.